CuriosityStream has transformed into a profitable, high-growth company with a scalable business. Read more on the company's ...

Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year ...

Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to comp ...

CorFlow Therapeutics AG (CorFlow) is pleased to announce the appointment of Chris O’Connell as Chairman of the Board of ...

Upgraded Huron to 'Buy' due to strong free cash-flow growth, attractive valuation ... As we see below on the technical chart, since breaking out above long-term consolidation in 2023, Huron's ...

In another slide titled 'Can I say the N-Word?', a flow chart outlined who is allowed to use the term, beginning with options for how employees identify themselves: white, a person of color but ...

Figure 1. CONSORT (Consolidated Standards of Reporting Trials) flowchart recruitment of participants. Baseline characteristics were similar between both groups (Table 1). The PRERISK score at ...

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies ...